Implementation and experimental validation of the high dose rate stereotactic treatment mode at Varian accelerators.

By Hoffmann Lone  

Acta Oncologica, Vol. 48, Iss. 2, 2009-02 ,pp. : 201-208

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic treatments of advanced non-small cell lung cancer

By Manegold Christian  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 187-196

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy treatments for small-cell lung cancer: past, present and future

By Whitehurst Matthew   Chiappori Alberto  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 517-525

Future Medicine

Access to resources Recommend Favorite

Conference Scene: Australia Lung Cancer Conference 2012: focus on systemic treatment of advanced non-small-cell lung cancer

By Vincent Mark  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 27-30

Future Medicine

Access to resources Recommend Favorite

Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue

By De Jaeger K.   Hoogeman M.S.   Engelsman M.   Seppenwoolde Y.   Damen E.M.F.   Mijnheer B.J.   Boersma L.J.   Lebesque J.V.  

Radiotherapy and Oncology, Vol. 69, Iss. 1, 2003-10 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite